Search fresh public links, source activity, and ready-to-use post angles for Hematologic Malignancies.
Fresh curated links around Hematologic malignancies are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Mantle Cell Lymphoma Isn't Just Renal InfiltrationIn a paper published in KI Reports, various GNs were reported with Mantle Cell lymphoma. When we think of kidney disease in mantle...
+ Flipbook textWhat is myeloma? Myeloma is cancer that affects a specific type of white blood cell, called a plasma cell, found in bone marrow. Plasma cells help people fight infec...
An immunotherapy typically used in advanced stages of multiple myeloma may be effective against an early form of the disease known as smoldering myeloma—offering a potential new op...
In the United States, 1.8 million people are living with or in remission from a type of blood cancer, either leukemia, lymphoma, myeloma, myelodysplastic syndromes (MDS), or myelop...
A groundbreaking advancement in cancer immunotherapy has emerged from collaborative research led by scientists at University College London (UCL) and the University of Oxford, who...
Acute lymphoblastic leukemia (ALL), a malignancy of the lymphoid progenitor cells, has long been a focus of intense biomedical research due to its aggressive nature and prevalence...
English+ Infographic text¿Qué es el mieloma? El mieloma es un cáncer que afecta a un tipo específico de glóbulo blanco, denominado plasmocito, que se encuentra en la médula ósea. L...
Early ASCO 2026 data show strong responses and improved safety with mesutoclax in high-risk MDS and AML. Hear what it may mean for treatment.
Patients with serious illness may gradually develop a form of “double awareness” — the ability to hold hope for continued living while also preparing for the possibility of dying.O...
RNA sequencing enabled comprehensive detection of clinically relevant gene fusions in acute leukemia, including rare rearrangements that conventional diagnostic methods failed to i...
Blood cancer, which includes lymphoma, leukemia, and multiple myeloma, is on the rise in the U.S., impacting 1.7 million Americans and accounting for 10% of all new cancer diagnose...
Eli Lilly presented encouraging Phase 1 results for AJ1-11095 at the European Hematology Association (EHA) annual meeting in Stockholm. The drug, a type II JAK2 inhibitor in develo...
With unmet need still high in AML, new approaches are exploring whether engaging immune responses could help improve long-term disease control.
T cells may be able to kill acute myeloid leukemia (AML) through an unexpected route that bypasses the usual way tumors are “seen.” Researchers at The University of Texas MD Anders...
In the evolving landscape of geriatric medicine, the challenge of predicting outcomes for older patients with complex hematological disorders has long confounded clinicians and res...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.